DaVita to Sell 29 Clinics to Get Approval on CDSI Bid, U.S. Says

DaVita Inc. (DVA) must sell 29 clinics that provide dialysis services to get U.S. approval for the company’s bid to buy CDSI I Holding Co., the Federal Trade Commission said.

Competition will be preserved in 22 markets with the divestment, which is part of a proposed settlement, the FTC said in a statement.

DaVita is the Denver-based provider of outpatient dialysis services, which are used to treat people with advanced kidney disease, according to the FTC. DaVita is seeking to buy for $689 million Nashville, Tennessee-based CDSI, the fifth-largest provider of such services.

Skip Thurman, a spokesman for DaVita, didn’t immediately return phone calls seeking comment.

To contact the reporter on this story: Jeff Bliss in Washington at jbliss@bloomberg.net

To contact the editor responsible for this story: Mark Silva in Washington at msilva34@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.